Bayforest Capital’s Core Scientific CORZ Stock Holding History

Bayforest Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,637	Closed	-$159K	–	999
2026 Q1	$159K	Buy	+10,637	New	+$181K	0.18%	198

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Bayforest Capital's CORZ Position: Q2 2026 in Review

Bayforest Capital sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 10,637 shares — an estimated $159K sold.

Bayforest Capital first reported a position in CORZ in Q1 2026 and held it in 1 quarter. The position peaked at $159K in Q1 2026. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Bayforest Capital reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
Bayforest Capital sold 10,637 Core Scientific shares in Q2 2026, an estimated $159K.
Bayforest Capital first reported a position in Core Scientific in Q1 2026 and held it in 1 quarter.
Bayforest Capital's Core Scientific position peaked at $159K in Q1 2026.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.